Medicines & vaccines · Brazil

Bio-Manguinhos (Fiocruz)

Federal vaccine producer that localised AstraZeneca COVID-19 vaccine production with technology transfer, is a WHO-prequalified yellow fever vaccine supplier, and is a WHO mRNA hub partner.

Headquarters
Rio de Janeiro, Brazil · Latin America
Value chain
Medicines & vaccines(Products); also Contract manufacturing
What that means
Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
Founded
1976
Ownership
State-owned
Website
bio.fiocruz.br
Relevance
Low at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures

In 2 capabilities

Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.

  1. Biotechnology & Health Technologies · Manufacture · listed #40 of 50

    Federal vaccine producer that localised AstraZeneca COVID-19 vaccine production with technology transfer, is a WHO-prequalified yellow fever vaccine supplier, and is a WHO mRNA hub partner.

    Relevance: Brazilian federal vaccine producer

    Source · en.wikipedia.org

  2. Biotechnology & Health Technologies · Manufacture · listed #47 of 50

    Fiocruz's immunobiologicals institute, Latin America's largest vaccine producer and a WHO-prequalified yellow fever vaccine supplier, also part of the mRNA hub network.

    Relevance: Latin America’s largest vaccine producer

    Source · en.wikipedia.org